BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT00088530 · COMPLETED

Trial details

NCT number: NCT00088530
Sponsor: CTI BioPharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2004-07-01
Primary completion: 2010-02-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.